Results 71 to 80 of about 757,915 (376)
Phage treatment of an aortic graft infected with Pseudomonas aeruginosa
Management of prosthetic vascular graft infections caused by Pseudomonas aeruginosa can be a significant challenge to clinicians. These infections often do not resolve with antibiotic therapy alone due to antibiotic resistance/tolerance by bacteria, poor
B. Chan+5 more
semanticscholar +1 more source
The Regulatory Network of Pseudomonas aeruginosa [PDF]
Abstract Background Pseudomonas aeruginosa is an important bacterial model due to its metabolic and pathogenic abilities, which allow it to interact and colonize a wide range of hosts, including plants and animals.
Galán-Vásquez, Edgardo+2 more
openaire +3 more sources
EFEK BERBAGAI KONSENTRASI EKSTRAK PEGAGAN (Centella \ud asiatica L) TERHADAP JUMLAH KOLONI DAN ZONA HAMBAT BAKTERI \ud Pseudomonas aeruginosa SECARA IN VITRO [PDF]
Pseudomonas aeruginosa is one species that can cause infectious diseases in humans. Pseudomonas aeruginosa in a small amount is often the normal flora in the intestine \ud (gastrointestinal tract) and human skin, human infection usually is opportunistic ...
NYONO, NYONO
core
A multifunctional hydroxyapatite (HAp) coating integrated with silver‐gallium liquid metal nanoparticles (HAp‐Ag‐GaNPs) exhibits dual antibacterial and osteogenic properties. It effectively inhibits Gram‐positive and Gram‐negative bacteria, including resistant strains, while enhancing bone regeneration.
Ngoc Huu Nguyen+17 more
wiley +1 more source
Microbe Profile: Pseudomonas aeruginosa: opportunistic pathogen and lab rat
Pseudomonas aeruginosa is a Gram-negative opportunistic pathogen and a model bacterium for studying virulence and bacterial social traits. While it can be isolated in low numbers from a wide variety of environments including soil and water, it can ...
S. Diggle, M. Whiteley
semanticscholar +1 more source
Responses of Pseudomonas aeruginosa to antimicrobials [PDF]
Infections caused by Pseudomonas aeruginosa often are hard to treat; inappropriate chemotherapy readily selects multidrug-resistant P. aeruginosa. This organism can be exposed to a wide range of concentrations of antimicrobials during treatment; learning more about the responses of P. aeruginosa to antimicrobials is therefore important.
Yuji Morita+2 more
openaire +4 more sources
Synergistic Activity of Fosfomycin, Ciprofloxacin, and Gentamicin Against Escherichia coli and Pseudomonas aeruginosa Biofilms [PDF]
Gram-negative (GN) rods cause about 10% periprosthetic joint infection (PJI) and represent an increasing challenge due to emergence of antimicrobial resistance.
Di Luca, Mariagrazia+4 more
core +1 more source
Biopolymers are sustainable, biodegradable alternatives to petroleum‐based plastics for food packaging. Its adoption is often limited by poor mechanical strength, barrier properties, and improved thermal stability through the incorporation of nanofillers.
Himakshi Baishya+2 more
wiley +1 more source
Cystic Fibrosis and Pseudomonas aeruginosa: the Host-Microbe Interface
In human pathophysiology, the clash between microbial infection and host immunity contributes to multiple diseases. Cystic fibrosis (CF) is a classical example of this phenomenon, wherein a dysfunctional, hyperinflammatory immune response combined with ...
Sankalp Malhotra, D. Hayes, D. Wozniak
semanticscholar +1 more source
Biomaterial Strategies for Targeted Intracellular Delivery to Phagocytes
Phagocytes are essential to a functional immune system, and their behavior defines disease outcomes. Engineered particles offer a strategic opportunity to target phagocytes, harnessing inflammatory modulation in disease. By tuning features like size, shape, and surface, these systems can modulate immune responses and improve targeted treatment for a ...
Kaitlyn E. Woodworth+2 more
wiley +1 more source